Exozymes Inc. (EXOZ) stock

EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$3.83−0.17 (-4.25%)

Close on Nov 13, 2026Market cap $35.55MP/E –Yield –

Exozymes operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2023 it was -2563.5%.

Period	Period end	Value	Change (pts)
FY2023	Dec 31, 2023	-2563.5%	–

See a number that looks wrong?